SVRA vs VRTX: Which Stock is Better?
Side-by-side comparison of Savara Inc and Vertex Pharmaceuticals Inc in 2026
SVRA
Savara Inc
$5.78
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | SVRA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.18B | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | -8140400.0% | 53.7% | VRTX |
Analyze SVRA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVRA or VRTX a better investment?
Comparing SVRA and VRTX: Savara Inc has a market cap of $1.18B while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVRA and VRTX?
SVRA (Savara Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVRA or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SVRA or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for SVRA.
Which company is more profitable: SVRA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -8140400.0% for SVRA.
Which is the larger company: SVRA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $1.18B for SVRA.
Should I buy SVRA or VRTX in 2026?
Both SVRA and VRTX have investment merit. SVRA trades at $5.78 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVRA and VRTX stock?
Key differences: Market Cap ($1.18B vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (0.0% vs 0.1%), Gross Margin (-8140400.0% vs 53.7%).